Article

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s Disease

2024-01-08

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> We profiled circulating plasma metabolites to identify systemic biochemical changes in clinical and biomarker-assisted diagnosis of Alzheimer’s disease (AD). <bold>Methods</bold> We used an untargeted approach with liquid chromatography coupled to high-resolution mass spectrometry to measure small molecule plasma metabolites from 150 clinically diagnosed AD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3922ff54-f74f-5692-b694-c6e3d5fcc78b
DOI: 10.21203/rs.3.rs-3346076/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseDOI 10.21203/rs.3.rs-3346076/v1Read

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseSemantic proximity Read

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Sets of Co-regulated Serum Lipids are Associated with Alzheimer Disease PathophysiologySemantic proximity Read

Integration of proteomics and metabolomics – insights into inflammation, metabolic dysregulation, and vascular aspects in ADSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.Semantic proximity Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Integrating large-scale serum metabolomics and <i>APOE</i> ε4 genotype status for the non-invasive detection of Alzheimer’s disease in the ADNI cohortSemantic proximity Read

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early StagesSemantic proximity Read